Ankylosing spondylitis clinical trials

Explore recruiting ankylosing spondylitis clinical trials.

Recruiting ankylosing spondylitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ankylosing spondylitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Study Participants with Active Axial Spondyloarthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis

Hungary, Poland, France, Belgium, Czechia, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tulisokibart in Participants With Radiographic Axial Spondyloarthritis (Ankylosing Spondylitis)

Netherlands, Germany, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis Followed by a Remission-Withdrawal Period

Germany, France, Bulgaria, Hungary, Poland, Spain +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis (UP-FOR-U)

Spain, Poland, Netherlands, France, Bulgaria, Germany

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3 randomized, placebo-controlled, double-blind, parallel-group program to evaluate efficacy and safety of filgotinib in adult subjects with active axial spondyloarthritis

Romania, Germany, Lithuania, Netherlands, Italy, Estonia +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLANE

Germany, Bulgaria, Poland, Czechia

Therapeutic use (Phase IV) EU CTIS Study details

Ankylosing spondylitis trials by city

Ankylosing spondylitis in Toronto Ankylosing spondylitis in Vancouver Ankylosing spondylitis in Montreal Ankylosing spondylitis in Calgary Ankylosing spondylitis in Edmonton Ankylosing spondylitis in Ottawa Ankylosing spondylitis in Winnipeg Ankylosing spondylitis in Quebec City Ankylosing spondylitis in Hamilton Ankylosing spondylitis in Kitchener Ankylosing spondylitis in London Ankylosing spondylitis in Halifax Ankylosing spondylitis in New York Ankylosing spondylitis in Los Angeles Ankylosing spondylitis in Chicago Ankylosing spondylitis in Houston

Other conditions

Sleep apnea Chronic cough Crohn's disease Ulcerative colitis Irritable bowel syndrome Celiac disease GERD Eosinophilic esophagitis Gastroparesis Rheumatoid arthritis Lupus Psoriatic arthritis Osteoarthritis Knee osteoarthritis Osteoporosis Sjogren's syndrome Scleroderma Fibromyalgia Psoriasis Eczema (atopic dermatitis) Acne Vitiligo Hidradenitis suppurativa Rosacea